Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy.

Shujie HuangYong TangHansheng WuQiuling ShiJiming TangXiaosong BenDongkun ZhangLiang XieHaiyu ZhouGang ChenSichao WangZhen GaoZefeng XieRixin ChenGuibin Qiao

Published in: Annals of surgical oncology (2023)

The current study demonstrated that a longitudinal patient-reported outcome (PRO) was an easily obtained, cost-effective, and noninvasive tool for predicting tumor responses to neoadjuvant immunochemotherapy.

Keyphrases

patient reported outcomes
diffuse large b cell lymphoma
rectal cancer
lymph node
anti inflammatory
radiation therapy